Bausch Health Companies Inc. Common Stock (BHC): Debt Offering News

BHC – Prices priced its previously announced offering of 9.250% senior notes due 2026.


Key Facts Surrounding This News Item


  • BHC had a POWR Rating of D (Sell) coming into today.
  • BHC was 0.25% above its 10-Day Moving Average coming into today.
  • BHC was -7.77% below its 20-Day Moving Average coming into today.
  • BHC was -18.47% below its 50-Day Moving Average coming into today.
  • BHC was -10.78% below its 100-Day Moving Average coming into today.
  • BHC was -2.40% below its 200-Day Moving Average coming into today.
  • BHC had returned -24.01% year-to-date leading up to today’s news, versus a +4.37% return from the benchmark S&P 500 during the same period.

More Info About Bausch Health Companies Inc. Common Stock (BHC)


Bausch Health Cos. Inc. (formerly) Valeant Pharmaceuticals is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter products, and medical devices, including contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices. The company was founded in 1983 and is based in Laval, Canada. View our full BHC ticker page with ratings, news, and more.

BHC at a Glance

BHC Current POWR Rating™
Overall POWR Rating™
BHC Current Price $23.65 1.99%
More BHC Ratings, Data, and News

BHC Price Reaction

The day of this event (Mar. 13, 2018)
BHC Closing Price$16.08 1.84%
BHC Volume8,596,100
51.21% from avg
Leading up to this event
BHC 1-mo return12.03%
After this event
BHC 1-day return6.84%
BHC 3-day return5.62%
BHC 5-day return1.19%

BHC Price Chart


The Top Stocks For 2019

More Bausch Health Companies Inc. Common Stock (BHC) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All BHC News
Page generated in 0.8677 seconds.